TOPVISN Stock Overview

An investment holding company, engages in the provision of ophthalmology and related medical consultancy services in Malaysia. More details

TOPVISN fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	2/6
Financial Health	5/6
Dividends	2/6

Rewards

Price-To-Earnings ratio (22.8x) is below the Healthcare industry average (25.6x)

Risk Analysis

Shares are highly illiquid

Shareholders have been diluted in the past year

Dividend of 2.58% is not well covered by free cash flows

Does not have a meaningful market cap (MYR96M)

My Notes

Capture your thoughts, links and company narrative

Topvision Eye Specialist Berhad Competitors

Metro Healthcare Berhad

KLSE:METRO

RM 180.9m

Optimax Holdings Berhad

KLSE:OPTIMAX

RM 326.0m

TMC Life Sciences Berhad

KLSE:TMCLIFE

RM 862.2m

Alpha IVF Group Berhad

KLSE:ALPHA

RM 1.6b

Price History & Performance

Summary of share price highs, lows and changes for Topvision Eye Specialist Berhad
Historical stock prices
Current Share Price	RM 0.31
52 Week High	RM 0.40
52 Week Low	RM 0.32
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	34.78%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	TOPVISN	MY Healthcare	MY Market
7D	n/a	-4.3%	-0.8%
1Y	n/a	21.3%	10.0%

Return vs Industry: Insufficient data to determine how TOPVISN performed against the MY Healthcare industry.

Return vs Market: Insufficient data to determine how TOPVISN performed against the MY Market.

Price Volatility

Is TOPVISN's price volatile compared to industry and market?
TOPVISN volatility
TOPVISN Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.0%
Market Average Movement	4.9%
10% most volatile stocks in MY Market	10.3%
10% least volatile stocks in MY Market	2.5%

Stable Share Price: TOPVISN's share price has been volatile over the past 3 months compared to the MY market.

Volatility Over Time: Insufficient data to determine TOPVISN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2010	n/a	Peter Chong	www.tvesc.com

Topvision Eye Specialist Berhad, an investment holding company, engages in the provision of ophthalmology and related medical consultancy services in Malaysia. The company offers various eye care services comprising cataract, diabetic retinopathy, vitreous and retinal diseases, glaucoma, corneal, anterior segment diseases, age-related macular degeneration, pterygium, dry eyes, lid disorder, children's eye disorder services, and other external eye problems, as well as eye examination, investigation, and refraction services. It also engages in the marketing of eye supplements and health food products, as well as retail sale of food and beverage.

Topvision Eye Specialist Berhad Fundamentals Summary

How do Topvision Eye Specialist Berhad's earnings and revenue compare to its market cap?
TOPVISN fundamental statistics
Market cap	RM 99.14m
Earnings (TTM)	RM 4.21m
Revenue (TTM)	RM 43.98m

22.8x

P/E Ratio

2.2x

P/S Ratio

Is TOPVISN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TOPVISN income statement (TTM)
Revenue	RM 43.98m
Cost of Revenue	RM 21.80m
Gross Profit	RM 22.18m
Other Expenses	RM 17.97m
Earnings	RM 4.21m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.014
Gross Margin	50.43%
Net Profit Margin	9.57%
Debt/Equity Ratio	33.7%

How did TOPVISN perform over the long term?

See historical performance and comparison

Dividends

2.6%

Current Dividend Yield

49%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 14:16
End of Day Share Price	2024/12/18 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Topvision Eye Specialist Berhad is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution